Patkowska E, Krzywdzinska A, Solarska I, Wojtas M, Prochorec-Sobieszek M
Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996833
PMC: 11853749.
DOI: 10.3390/cimb47020111.
Wurm S, Waltersdorfer M, Loindl S, Moritz J, Herzog S, Bachmaier G
Wien Klin Wochenschr. 2024; .
PMID: 39527258
DOI: 10.1007/s00508-024-02463-w.
Diamantidis M
J Clin Med. 2024; 13(20).
PMID: 39458104
PMC: 11509401.
DOI: 10.3390/jcm13206154.
Loscocco G, Vannucchi A
Ann Hematol. 2023; 102(8):1973-1984.
PMID: 37286874
PMC: 10345021.
DOI: 10.1007/s00277-023-05288-1.
Yang Y, Shu Y, Tang Y, Zhao S, Jia Y, Ji J
Cancer Med. 2023; 12(8):9156-9166.
PMID: 36916780
PMC: 10166975.
DOI: 10.1002/cam4.5654.
Spatial heterogeneity and differential treatment response of acute myeloid leukemia and relapsed/refractory extramedullary disease after allogeneic hematopoietic cell transplantation.
Kunadt D, Herold S, Poitz D, Wagenfuhr L, Kretschmann T, Sockel K
Ther Adv Hematol. 2022; 13:20406207221115005.
PMID: 36050938
PMC: 9425876.
DOI: 10.1177/20406207221115005.
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.
Eckardt J, Stolzel F, Kunadt D, Rollig C, Stasik S, Wagenfuhr L
J Hematol Oncol. 2022; 15(1):60.
PMID: 35562747
PMC: 9107142.
DOI: 10.1186/s13045-022-01267-7.
Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in a mouse transplantation model: Hoxa11 in myeloid sarcoma formation.
Fu J, Wen C, Yen T, Shih L
Neoplasia. 2022; 29:100802.
PMID: 35500545
PMC: 9065885.
DOI: 10.1016/j.neo.2022.100802.
Serial Analysis and Comparison of Mutation Profiles in Decitabine-treated Myeloid Sarcoma and Subsequent Acute Myeloid Leukemia Using Next-Generation Sequencing.
Park H, Son S, Kwon J
Ann Lab Med. 2022; 42(5):602-605.
PMID: 35470279
PMC: 9057818.
DOI: 10.3343/alm.2022.42.5.602.
Extramedullary acute myeloid leukemia (eAML): Retrospective single center cohort study on clinico-pathological, molecular analysis and survival outcomes.
Halahleh K, Alhalaseh Y, Al-Rimawi D, Dana W, Alrabi K, Kamal N
Ann Med Surg (Lond). 2021; 72:102894.
PMID: 34815855
PMC: 8593591.
DOI: 10.1016/j.amsu.2021.102894.
Two autopsy cases of pulmonary leukemic infiltration mimicking severe pneumonia in patients with acute myeloid leukemia.
Iizuka H, Mori Y, Fukuda Y, Iwao N, Koike M, Noguchi M
Leuk Res Rep. 2021; 16:100269.
PMID: 34631406
PMC: 8488243.
DOI: 10.1016/j.lrr.2021.100269.
Gastric Myeloid Sarcoma Mimicking a Scirrhous Gastric Cancer.
Taminishi-Katsuragawa Y, Shimura Y, Inoue Y, Matsumura-Kimoto Y, Tsukamoto T, Mizutani S
Intern Med. 2021; 61(8):1231-1235.
PMID: 34615821
PMC: 9107997.
DOI: 10.2169/internalmedicine.7986-21.
Case report: Rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations.
Wu D, Lu X, Yan X, Gao R
Diagn Pathol. 2021; 16(1):82.
PMID: 34465355
PMC: 8406562.
DOI: 10.1186/s13000-021-01141-z.
miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms.
Mayer M, Berg J, Perfler B, Hatzl S, Herzog S, Bachmaier G
Ann Hematol. 2021; 100(11):2845-2847.
PMID: 34291333
DOI: 10.1007/s00277-021-04598-6.
The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case report.
Shatilova A, Girshova L, Zaytsev D, Budaeva I, Mirolyubova Y, Ryzhkova D
BMC Womens Health. 2021; 21(1):184.
PMID: 33933047
PMC: 8088676.
DOI: 10.1186/s12905-021-01328-y.
Characteristics and transplant outcome of myeloid sarcoma: a single-institute study.
Shan M, Lu Y, Yang M, Wang P, Lu S, Zhang L
Int J Hematol. 2021; 113(5):682-692.
PMID: 33511548
DOI: 10.1007/s12185-021-03081-2.
Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrow.
Engel N, Reinert J, Borchert N, Panagiota V, Gabdoulline R, Thol F
Ann Hematol. 2020; 100(2):499-503.
PMID: 33108522
PMC: 7817572.
DOI: 10.1007/s00277-020-04313-x.
Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis.
Caraffini V, Geiger O, Rosenberger A, Hatzl S, Perfler B, Berg J
Haematologica. 2019; 105(2):375-386.
PMID: 31097632
PMC: 7012480.
DOI: 10.3324/haematol.2018.209650.
Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass.
Bao H, Gao J, Chen Y, Altman J, Frankfurt O, Wilson A
Diagn Pathol. 2019; 14(1):26.
PMID: 30922345
PMC: 6440110.
DOI: 10.1186/s13000-019-0804-6.
Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline.
de Haas V, Ismaila N, Advani A, Arber D, Dabney R, Patel-Donelly D
J Clin Oncol. 2018; 37(3):239-253.
PMID: 30523709
PMC: 6338392.
DOI: 10.1200/JCO.18.01468.